A nerve-sparing technique (NeuroSAFE) reduced erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer. A year after surgery, patients randomized to ...

A TURBT allows examination beyond the bladder. Study findings support attempting nerve-sparing surgery in patients with confirmed high-risk prostate cancer. Nerve-sparing radical prostatectomy (NSRP) ...

Can you have intimacy after prostate removal? Yes. It just might feel a little different. Recovery takes time, and everyone heals at their own pace. Some changes in intimate function are common after ...

In recent years, preservation of these nerves has been made possible by robotic surgery technology 1 that gives the surgeon the precision required to peel off and retain the outermost layers of the ...

Real-world, prospective data corroborate trial results showing functional declines after prostate cancer surgery, despite progress in nerve-sparing techniques. Active surveillance best preserves ...

Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function. Researchers have found that the use of the NeuroSAFE technique to guide ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...

Localized prostate cancer treatments include radical prostatectomy and focal therapy, with the latter targeting only cancerous areas to preserve healthy tissue. Focal therapy allows for active ...

The myth is that prostate cancer treatment destroys men’s erections. The truth is more complicated. Men facing treatment for this disease should prepare themselves emotionally for permanent erectile ...

A new study may provide help to men newly diagnosed with prostate cancer who are faced with a daunting array of treatment options. The study tracked 10-year outcomes and treatment side effects for ...

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population. The CEASAR ...